Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.

O'Malley SS, Zweben A, Fucito LM, Wu R, Piepmeier ME, Ockert DM, Bold KW, Petrakis I, Muvvala S, Jatlow P, Gueorguieva R.

JAMA Psychiatry. 2017 Dec 20. doi: 10.1001/jamapsychiatry.2017.3544. [Epub ahead of print]

PMID:
29261824
2.

The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.

Zweben A, Piepmeier ME, Fucito L, O'Malley SS.

J Subst Abuse Treat. 2017 Jun;77:72-78. doi: 10.1016/j.jsat.2017.04.001. Epub 2017 Apr 4.

PMID:
28476276
3.

Commentary on the adding individual psychotherapy after relapse in a pharmacotherapy trial: commentary on the PREDICT study.

Zweben A.

Alcohol Clin Exp Res. 2014 Aug;38(8):2164-6. doi: 10.1111/acer.12485. Epub 2014 Jul 1.

4.

Sustaining motivational interviewing: a meta-analysis of training studies.

Schwalbe CS, Oh HY, Zweben A.

Addiction. 2014 Aug;109(8):1287-94. doi: 10.1111/add.12558. Epub 2014 May 29.

PMID:
24661345
5.

Does session attendance by a supportive significant other predict outcomes in individual treatment for alcohol use disorders?

Hunter-Reel D, Witkiewitz K, Zweben A.

Alcohol Clin Exp Res. 2012 Jul;36(7):1237-43. doi: 10.1111/j.1530-0277.2011.01719.x. Epub 2012 Feb 10.

6.

Effective Strategies for Maintaining Research Participation in Clinical Trials.

Zweben A, Fucito LM, O'Malley SS.

Drug Inf J. 2009 Jul;43(4). doi: 10.1177/009286150904300411.

7.

Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study.

LoCastro JS, Youngblood M, Cisler RA, Mattson ME, Zweben A, Anton RF, Donovan DM.

J Stud Alcohol Drugs. 2009 Mar;70(2):186-96.

8.

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group.

Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.

9.

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.

Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x. Epub 2008 Jul 9.

10.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
11.

Addressing substance abuse in health care settings.

Miller WR, Baca C, Compton WM, Ernst D, Manuel JK, Pringle B, Schermer CR, Weiss RD, Willenbring ML, Zweben A.

Alcohol Clin Exp Res. 2006 Feb;30(2):292-302.

PMID:
16441278
12.

Applying clinical significance methodology to alcoholism treatment trials: determining recovery outcome status with individual- and population-based measures.

Cisler RA, Kowalchuk RK, Saunders SM, Zweben A, Trinh HQ.

Alcohol Clin Exp Res. 2005 Nov;29(11):1991-2000.

PMID:
16340456
13.

Origins, issues and options in the development of the combined behavioral intervention.

Longabaugh R, Zweben A, Locastro JS, Miller WR.

J Stud Alcohol Suppl. 2005 Jul;(15):179-87; discussion 168-9.

PMID:
16223069
14.

Quality of life as an outcome measure in alcoholism treatment research.

Donovan D, Mattson ME, Cisler RA, Longabaugh R, Zweben A.

J Stud Alcohol Suppl. 2005 Jul;(15):119-39; discussion 92-3. Review.

PMID:
16223064
15.

Recruiting and retaining participants in a combined behavioral and pharmacological clinical trial.

Zweben A, Barrett D, Berger L, Murray KT.

J Stud Alcohol Suppl. 2005 Jul;(15):72-81; discussion 65.

PMID:
16223059
16.

Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence.

Weiss RD, Locastro JS, Swift R, Zweben A, Miller WR, Longabaugh R, Hosking JD.

J Stud Alcohol Suppl. 2005 Jul;(15):43-9; discussion 33.

PMID:
16223055
17.

When worlds collide: blending the divergent traditions of pharmacotherapy and-psychotherapy outcome research.

Miller WR, Locastro JS, Longabaugh R, O'Malley S, Zweben A.

J Stud Alcohol Suppl. 2005 Jul;(15):17-23; discussion 6-7.

PMID:
16223052
18.

Experimental components analysis of brief theory-based HIV/AIDS risk-reduction counseling for sexually transmitted infection patients.

Kalichman SC, Cain D, Weinhardt L, Benotsch E, Presser K, Zweben A, Bjodstrup B, Swain GR.

Health Psychol. 2005 Mar;24(2):198-208.

PMID:
15755234
19.

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.

Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S.

J Clin Psychopharmacol. 2004 Aug;24(4):421-8.

PMID:
15232334
20.

Clinical and methodological utility of a composite outcome measure for alcohol treatment research.

Zweben A, Cisler RA.

Alcohol Clin Exp Res. 2003 Oct;27(10):1680-5. Review.

PMID:
14574241

Supplemental Content

Loading ...
Support Center